Hepatitis C: An epidemiological review

Journal of Viral Hepatitis

Volumn 9, Issue 2, 2002, Pages 84-100

  Memon, M I ^a,c   Memon, M A ^b  

^a UNIVERSITY OF BOLTON   (United Kingdom)

^b QUEEN S MEDICAL CENTRE   (United Kingdom)

^c NONE   (United Kingdom)

Author keywords

Epidemiology; Etiology; Hepatitis C; Prevention and control; Risk factors; Statistics and numerical data

Indexed keywords

BLOOD TRANSFUSION; DATA BASE; DRUG USE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE PERSONNEL; HEPATITIS C; HEPATITIS C VIRUS; HIGH RISK POPULATION; HOUSEHOLD; HUMAN; INFECTION RISK; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; VERTICAL TRANSMISSION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; DISEASE TRANSMISSION, PATIENT-TO-PROFESSIONAL; DISEASE TRANSMISSION, VERTICAL; HEALTH PERSONNEL; HEPACIVIRUS; HEPATITIS C; HUMANS; IATROGENIC DISEASE; RISK FACTORS; RISK-TAKING; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS; WORLD HEALTH;

EID: 0036903655     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2002.00329.x     Document Type: Review

References (295)

1. Choo QL et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244: 359-362.
2. Anonymous. Hepatitis C: Global prevalence. Weekly Epidemiol Record 1997; 72: 341-344.
3. Mast EE et al. Strategies to prevent and control hepatitis B and C virus infections: A global perspective. Vaccine 1999; 17: 1730-1733.
4. Alter MJ. Epidemiology of hepatitis C in the West. Semin Liver Dis 1995; 15: 5-14.
5. van der Poel CL et al. Hepatitis C virus six years on. Lancet 1994; 344: 1475-1479.
6. Di Bisceglie AM et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology 1991; 14: 969-974.
7. Saito I et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma. Proc Natl Acad Sci USA 1990; 87: 6547-6549.
8. Lee HS et al. Predominant etiologic association of hepatitis C virus with hepatocellular carcinoma compared with hepatitis B virus in elderly patients in a hepatitis B-endemic area. Cancer 1993; 72: 2564-2567.
9. Van Damme P et al. Epidemiology of hepatitis B and C in Europe. Acta Gastroenterologica Belgica 1998; 61: 175-182.
10. Fried MW et al. Absence of hepatitis C viral RNA from saliva and semen of patients with chronic hepatitis C. Gastroenterology 1992; 102: 1306-1308.
11. Kotwal GJ et al. Detection of hepatitis C virus-specific antigens in semen from non-A, non-B hepatitis patients. Dig Dis Sci 1992; 37: 641-644.
12. Sharara AI et al. Hepatitis C. Ann Intern Med 1996; 125: 658-668.
13. Conry-Cantilena C et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334: 1691-1696.
14. Alter HJ et al. Donor transaminase and recipient hepatitis. Impact on blood transfusion services. JAMA 1981; 246: 630-634.
15. Aach RD et al. Serum alanine aminotransferase of donors in relation to the risk of non-A,non-B hepatitis in recipients: The transfusion-transmitted viruses study. N Engl J Med 1981; 304: 989-994.
16. Widell A et al. Relation between donor transaminase and recipient hepatitis non-A, non-B in Sweden. Vox Sang 1988; 54: 154-159.
17. Reesink HW et al. HCV and blood transfusion. Arch Virol Suppl 1992; 4: 241-243.
18. Aymard JP et al. Post-transfusion non-A, non-B hepatitis after cardiac surgery. Prospective analysis of donor blood anti-HBc antibody as a predictive indicator of the occurrence of non-A, non-B hepatitis in recipients. Vox Sang 1986; 51: 236-238.
19. Esteban JI et al. Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 1990; 323: 1107-1112.
20. Aach RD et al. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with first- and second-generation assays. N Engl J Med 1991; 325: 1325-1329.
21. Barrera JM et al. Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 1991; 115: 596-600.
22. Elia GF et al. Incidence of anti-hepatitis C virus antibodies in non-A, non-B post-transfusion hepatitis in an area of northern Italy. Infection 1991; 19: 336-339.
23. Mattsson L et al. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden. Infection 1991; 19: 309-312.
24. Jullien AM et al. Impact of screening donor blood for alanine aminotransferase and antibody to hepatitis B core antigen on the risk of hepatitis C virus transmission. Eur J Clin Microbiol Infect Dis 1993; 12: 668-672.
25. Donahue JG et al. The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 1992; 327: 369-373.
26. Farci P et al. A long-term study of hepatitis C virus replication in non-A, non-B hepatitis. N Engl J Med 1991; 325: 98-104.
27. Houghton M et al. Molecular biology of the hepatitis C viruses: Implications for diagnosis, development and control of viral disease. Hepatology 1991; 14: 381-388.
28. Bukh J et al. Sequence analysis of the core gene of 14 hepatitis C virus genotypes. Proc Natl Acad Sci USA 1994; 91: 8239-8243.
29. Nowicki MJ et al. The hepatitis C virus: Identification, epidemiology, and clinical controversies. J Pediatr Gastroenterol Nutrition 1995; 20: 248-274.
30. Lai ME et al. Evaluation of antibodies to hepatitis C virus in a long-term prospective study of posttransfusion hepatitis among thalassemic children: Comparison between first-and second-generation assay. J Pediatr Gastroenterol Nutrition 1993; 16: 458-464.
31. Khalifa AS et al. Prevalence of hepatitis C viral antibody in transfused and nontransfused Egyptian children. Am J Trop Med Hyg 1993; 49: 316-321.
32. Fink FM et al. Association of hepatitis C virus infection with chronic liver disease in paediatric cancer patients. Eur J Pediatr 1993; 152: 490-492.
33. Kanesaki T et al. Hepatitis C virus infection in children with hemophilia: Characterization of antibody response to four different antigens and relationship of antibody response, viremia, and hepatic dysfunction. J Pediatr 1993; 123: 381-387.
34. Eyster ME et al. Natural history of hepatitis C virus infection in multitransfused hemophiliacs: Effect of coinfection with human immunodeficiency virus. The Multicenter Hemophilia Cohort Study. J Acquir Immune Defic Syndr 1993; 6: 602-610.
35. Makris M et al. Hepatitis C antibody and chronic liver disease in haemophilia. Lancet 1990; 335: 1117-1119.
36. Pawlotsky JM et al. Chronic hepatitis C after high-dose intravenous immunoglobulin. Transfusion 1994; 34: 86-87.
37. Maisonneuve P et al. Antibody to hepatitis C (anti C 100-3) in French hemophiliacs. Nouvelle Revue Francaise D Hematologie 1991; 33: 263-266.
38. Yu MW et al. Hepatitis C transmission associated with intravenous immunoglobulins. Lancet 1995; 345: 1173-1174.
39. Schneider LC et al. Intravenous immunoglobulin and hepatitis C virus: The Boston episode. Clin Ther 1996; 18 (suppl B): 108-109.
40. Bresee JS et al. Hepatitis C virus infection associated with administration of intravenous immune globulin. A cohort study. JAMA 1996; 276: 1563-1567.
41. Mauser-Bunschoten EP et al. Hepatitis C infection and viremia in Dutch hemophilia patients. J Med Virol 1995; 45: 241-246.
42. Resti M et al. Prevalence of hepatitis C virus antibody in beta-thalassemic polytransfused children in a long-term follow-up. Vox Sang 1991; 60: 246-247.
43. Bortolotti F et al. Posttransfusion and community-acquired hepatitis C in childhood. J Pediatr Gastroenterol Nutr 1994; 18: 279-283.
44. Tagariello G et al. Hepatitis C virus genotypes and severity of chronic liver disease in haemophiliacs. Br J Haematol 1995; 91: 708-713.
45. Makris M et al. The natural history of chronic hepatitis C in haemophiliacs. Br J Haematol 1996; 94: 746-752.
46. Locasciulli A et al. Hepatitis C virus serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 1993; 82: 2564-2567.
47. Ribas A et al. How important is hepatitis C virus (HCV)-infection in persons with acute leukemia? Leukemia Res 1997; 21: 785-788.
48. Cesaro S et al. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997; 90: 1315-1320.
49. Locasciulli A et al. Hepatitis C virus infection and liver failure in patients undergoing allogeneic bone marrow transplantation. Bone Marrow Transplant 1995; 16: 407-411.
50. Diego JM et al. Hepatitis C in dialysis and transplantation. Curr Opin Nephrol Hypertens 1996; 5: 497-503.
51. Fabrizi F et al. Detection of de novo hepatitis C virus infection by polymerase chain reaction in hemodialysis patients. Am J Nephrol 1999; 19: 383-388.
52. Izopet J et al. Molecular evidence for nosocomial transmission of hepatitis C virus in a French hemodialysis unit. J Med Virol 1999; 58: 139-144.
53. Sandhu J et al. Hepatitis C prevalence and risk factors in the northern Alberta dialysis population. Am J Epidemiol 1999; 150: 58-66.
54. Lettau LA. The A, B, C, D, and E of viral hepatitis: Spelling out the risks for healthcare workers. Infect Control Hosp Epidemiol 1992; 13: 77-81.
55. van der Poel CL et al. Hepatitis C virus: Epidemiology, transmission and prevention. Curr Stud Hematol Blood Transfus 1998: 208-236
56. Pru CE et al. Hepatitis C transmission through dialysis machines. ASAIO J 1994; 40: M889-91.
57. McLaughlin KJ et al. Nosocomial transmission of hepatitis C virus within a British dialysis centre. Nephrol Dialysis Transplant 1997; 12: 304-309.
58. Irish DN et al. Identification of hepatitis C virus serocon-version resulting from nosocomial transmission on a haemodialysis unit: Implications for infection control and laboratory screening. J Med Virol 1999; 59: 135-140.
59. Okuda K et al. Mode of hepatitis C infection not associated with blood transfusion among chronic hemodialysis patients. J Hepatol 1995; 23: 28-31.
60. Fabrizi F et al. Incidence of seroconversion for hepatitis C virus in chronic haemodialysis patients: A prospective study. Nephrol Dialysis Transplant 1994; 9: 1611-1615.
61. Schneeberger PM et al. Infection control of hepatitis C in Dutch dialysis centres [news]. Nephrol Dialysis Transplant 1998; 13: 3037-3040.
62. Huraib S et al. High prevalence of and risk factors for hepatitis C in haemodialysis patients in Saudi Arabia: A need for new dialysis strategies. Nephrol Dialysis Transplant 1995; 10: 470-474.
63. Gilli P et al. Prevention of hepatitis C virus in dialysis units. Nephron 1995; 70: 301-306.
64. Esteban JI et al. Transmission of hepatitis C virus by a cardiac surgeon. N Engl J Med 1996; 334: 555-560.
65. Schvarcz R et al. Nosocomial transmission of hepatitis C virus. Infection 1997; 25: 74-77.
66. Allander T et al. Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward. Lancet 1995; 345: 603-607.
67. Mitsui T et al. Hepatitis C virus infection in medical personnel after needlestick accident. Hepatology 1992; 16: 1109-1114.
68. Kelen GD et al. Hepatitis B and hepatitis C in emergency department patients. N Engl J Med 1992; 326: 1399-1404.
69. Klein RS et al. Occupational risk for hepatitis C virus infection among New York City dentists. Lancet 1991; 338: 1539-1542.
70. Zuckerman J et al. Prevalence of hepatitis C antibodies in clinical health-care workers. Lancet 1994; 343: 1618-1620.
71. Petrosillo N et al. Prevalence of hepatitis C antibodies in health-care workers. Italian Study Group on Blood-borne Occupational Risk in Dialysis [letter; comment]. Lancet 1994; 344: 339-340.
72. Hernandez ME et al. Risk of needle-stick injuries in the transmission of hepatitis C virus in hospital personnel. J Hepatol 1992; 16: 56-58.
73. Sodeyama T et al. Detection of hepatitis C virus markers and hepatitis C virus genomic-RNA after needlestick accidents. Arch Intern Med 1993; 153: 1565-1572.
74. Arai Y et al. A prospective study of hepatitis C virus infection after needlestick accidents. Liver 1996; 16: 331-334.
75. Everhart JE et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990; 112: 544-545.
76. Deny P et al. Low rate of hepatitis C virus (HCV) transmission within the family. J Hepatol 1992; 14: 409-410.
77. Mondello P et al. Anti-HCV antibodies in household contacts of patients with cirrhosis of the liver - Preliminary results. Infection 1992; 20: 51-52.
78. Bellobuono A et al. Intrafamilial spread of hepatitis C virus. Transfusion 1991; 31: 475.
79. Scaraggi FA et al. Intrafamilial and sexual transmission of hepatitis C virus [letter; comment]. Lancet 1993; 342: 1300-1302.
80. Camarero C et al. Horizontal transmission of hepatitis C virus in households of infected children. J Pediatr 1993; 123: 98-99.
81. Esteban JI et al. Hepatitis C virus antibodies among risk groups in Spain. Lancet 1989; 2: 294-297.
82. Caporaso N et al. Spread of hepatitis C virus infection within families. Investigators of an Italian Multicenter Group. J Viral Hepat 1998; 5: 67-72.
83. Guadagnino V et al. Hepatitis C virus infection in family setting. Eur J Epidemiol 1998; 14: 229-232.
84. Tanaka K et al. Heterosexual transmission of hepatitis C virus among married couples in southwestern Japan. Int J Cancer 1997; 72: 50-55.
85. Kao JH et al. Transmission of hepatitis C virus between spouses: The important role of exposure duration. Am J Gastroenterol 1996; 91: 2087-2090.
86. Thomas DL et al. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore - An analysis of 309 sex partnerships. J Infect Dis 1995; 171: 768-775.
87. Hess G et al. Hepatitis C virus and sexual transmission. Lancet 1989; 2: 987.
88. Tedder RS et al. Hepatitis C virus: Evidence for sexual transmission. BMJ 1991; 302: 1299-1302.
89. Bodsworth NJ et al. Hepatitis C virus infection in a large cohort of homosexually active men: Independent associations with HIV-1 infection and injecting drug use but not sexual behaviour. Genitourin Med 1996; 72: 118-122.
90. Koff RS. The low efficiency of maternal-neonatal transmission of hepatitis C virus: How certain are we? [Editorial comment] Ann Intern Med 1992; 117: 967-969.
91. Weintrub PS et al. Hepatitis C virus infection in infants whose mothers took street drugs intravenously. J Pediatr 1991; 119: 869-874.
92. Giovannini M et al. Maternal-infant transmission of hepatitis C virus and HIV infections: A possible interaction. Lancet 1990; 335: 1166.
93. Wejstal R et al. Mother to infant transmission of hepatitis C virus infection. J Med Virol 1990; 30: 178-180.
94. Wejstal R et al. Mother-to-infant transmission of hepatitis C virus. Ann Intern Med 1992; 117: 887-890.
95. Novati R et al. Mother-to-child transmission of hepatitis C virus detected by nested polymerase chain reaction. J Infect Dis 1992; 165: 720-723.
96. Thaler MM et al. Vertical transmission of hepatitis C virus. Lancet 1991; 338: 17-18.
97. Paccagnini S et al. Perinatal transmission and manifestation of hepatitis C virus infection in a high risk population. Pediatr Infect Dis J 1995; 14: 195-199.
98. Tanzi E et al. Is HCV transmitted by the vertical/perinatal route? Arch Virol Suppl 1993; 8: 229-234.
99. Aizaki H et al. Mother-to-child transmission of a hepatitis C virus variant with an insertional mutation in its hyper-variable region. J Hepatol 1996; 25: 608-613.
100. Matsubara T et al. Mother-to-infant transmission of hepatitis C virus: A prospective study. Eur J Pediatr 1995; 154: 973-978.
101. Maggiore G et al. Vertical transmission of hepatitis C [letter; comment]. Lancet 1995; 345: 1122.
102. Uehara S et al. The incidence of vertical transmission of hepatitis C virus. Tohoku J Exp Med 1993; 171: 195-202.
103. Marcellin P et al. Prevalence of hepatitis C virus infection in asymptomatic anti-HIV1 negative pregnant women and their children. Dig Dis Sci 1993; 38: 2151-2155.
104. Roudot-Thoraval F et al. Lack of mother-to-infant transmission of hepatitis C virus in human immunodeficiency virus-seronegative women: A prospective study with hepatitis C virus RNA testing. Hepatology 1993; 17: 772-777.
105. Reinus JF et al. Failure to detect vertical transmission of hepatitis C virus. Ann Intern Med 1992; 117: 881-886.
106. Fischler B et al. Vertical transmission of hepatitis C virus infection. Scand J Infect Dis 1996; 28: 353-356.
107. Sabatino G et al. Vertical transmission of hepatitis C virus: An epidemiological study on 2,980 pregnant women in Italy. Eur J Epidemiol 1996; 12: 443-447.
108. Kuroki T et al. Vertical transmission of hepatitis C virus (HCV) detected by HCV-RNA analysis. Gut 1993; 34: S52-53.
109. Lam JP et al. Infrequent vertical transmission of hepatitis C virus. J Infect Dis 1993; 167: 572-576.
110. Ohto H et al. Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group. N Engl J Med 1994; 330: 744-750.
111. Lin HH et al. Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus. J Infect Dis 1994; 169: 638-641.
112. Ni YH et al. Temporal profile of hepatitis C virus antibody and genome in infants born to mothers infected with hepatitis C virus but without human immunodeficiency virus coinfection. J Hepatol 1994; 20: 641-645.
113. Gonzalez A et al. Efficacy of screening donors for antibodies to the hepatitis C virus to prevent transfusion-associated hepatitis: Final report of a prospective trial. Hepatology 1995; 22: 439-445.
114. Resti M et al. Mother to child transmission of hepatitis C virus: Prospective study of risk factors and timing of infection in children born to women seronegative for HIV-1. Tuscany Study Group on Hepatitis C Virus Infection. BMJ 1998; 317: 437-441.
115. Zanetti AR et al. A prospective study on mother-to-infant transmission of hepatitis C virus. Intervirology 1998; 41: 208-212.
116. Weiner AJ et al. A unique, predominant hepatitis C virus variant found in an infant born to a mother with multiple variants. J Virol 1993; 67: 4365-4368.
117. Lin HH et al. Least microtransfusion from mother to fetus in elective cesarean delivery. Obstet Gynecol 1996; 87: 244-248.
118. Nagata I et al. Mother-to-infant transmission of hepatitis C virus. J Pediatr 1992; 120: 432-434.
119. Ogasawara S et al. Hepatitis C virus RNA in saliva and breastmilk of hepatitis C carrier mothers. Lancet 1993; 341: 561.
120. Lamden KH et al. Hepatitis B and hepatitis C virus infections: Risk factors among drug users in Northwest England. J Infect 1998; 37: 260-269.
121. Bell J et al. Hepatitis C virus in intravenous drug users. Med J Aust 1990; 153: 274-276.
122. Medin C et al. Seroconversion to hepatitis C virus in dialysis patients: A retrospective and prospective study. Nephron 1993; 65: 40-45.
123. Mansell CJ et al. Epidemiology of hepatitis C in the East. Semin Liver Dis 1995; 15: 15-32.
124. Chang CJ et al. Seroepidemiology of hepatitis C virus infection among drug abusers in southern Taiwan. J Formosan Med Assoc 1998; 97: 826-829.
125. Stark K et al. Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin. Scand J Infect Dis 1995; 27: 331-337.
126. Guadagnino V et al. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. J Clin Lab Immunol 1995; 47: 1-9.
127. Fairley CK et al. Epidemiology and hepatitis C virus in Victoria. Med J Aust 1990; 153: 271-273.
128. Garner JJ et al. Prevalence of hepatitis C infection in pregnant women in South Australia. Med J Aust 1997; 167: 470-472.
129. Tao QM et al. Seroepidemiology of HCV and HBV infection in northern China. Gastroenterol Japon 1991; 26 (Suppl. 3): 156-158.
130. Darwish MA et al. High seroprevalence of hepatitis A, B, C, and E viruses in residents in an Egyptian village in The Nile Delta: A pilot study. Am J Trop Med Hyg 1996; 54: 554-558.
131. Dubois F et al. Hepatitis C in a French population-based survey, 1994 seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. Hepatology 1997; 25: 1490-1496.
132. Richard-Lenoble D et al. Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon). Am J Trop Med Hyg 1995; 53: 338-341.
133. Martinson FE et al. Seroepidemiological survey of hepatitis B and C virus infections in Ghanaian children. J Med Virol 1996; 48: 278-283.
134. Jeannel D et al. Evidence for high genetic diversity and long-term endemicity of hepatitis C virus genotypes 1 and 2 in West Africa. J Med Virol 1998; 55: 92-97.
135. Nakata S et al. Hepatitis C and B virus infections in populations at low or high risk in Ho Chi Minh and Hanoi. Vietnam J Gastroenterol Hepatol 1994; 9: 416-419.
136. Chan GC et al. Prevalence of hepatitis C infection in Hong Kong. J Gastroenterol Hepatol 1992; 7: 117-120.
137. Reddy PH et al. Hepatitis virus markers in the Baiga tribal population of Madhya Pradesh, India. Trans R Soc Trop Med Hyg 1995; 89: 620.
138. Marranconi F et al. Prevalence of anti-HCV and risk factors for hepatitis C virus infection in healthy pregnant women. Infection 1994; 22: 333-337.
139. Osella AR et al. Epidemiology of hepatitis C virus infection in an area of Southern Italy. J Hepatol 1997; 27: 30-35.
140. Guadagnino V et al. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: A community-based survey in southern Italy. Hepatology 1997; 26: 1006-1011.
141. Tajima K et al. Natural horizontal transmission of HCV in microepidemic town in Japan. Lancet 1991; 337: 1410-1411.
142. Tibbs CJ et al. Prevalence of hepatitis C in tropical communities: The importance of confirmatory assays. J Med Virol 1991; 34: 143-147.
143. Kim YS et al. Prevalence of hepatitis C virus antibody among Korean adults. J Korean Med Sci 1992; 7: 333-336.
144. Morvan JM et al. Anti-HCV antibody prevalence among an asymptomatic population living in two villages in Madagascar. Trans R Soc Trop Med Hyg 1994; 88: 657.
145. Ahmed SD et al. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 1998; 37: 248-251.
146. Miller J et al. The epidemiology and control of hepatitis C in New Zealand. Commun Dis NZ 1993; 93: 33-41 (Abstract).
147. Perez OM et al. Prevalence of antibodies to hepatitis A, B, C, and E viruses in a healthy population in Leon. Nicaragua Am J Trop Med Hyg 1996; 55: 17-21.
148. Oshita M et al. Prevalence of hepatitis C virus in family members of patients with hepatitis C. J Med Virol 1993; 41: 251-255.
149. Luby SP et al. The relationship between therapeutic injections and high prevalence of hepatitis C infection in Hafizabad. Pakistan Epidemiol Infect 1997; 119: 349-356.
150. Baumgart KW et al. Hepatitis C virus in the central province of Papua New Guinea [letter; comment]. Med J Aust 1993; 159: 284-285.
151. Turner PF. Hepatitis C virus in the Western Province of Papua New Guinea. Med J Aust 1993; 158: 140.
152. Hyams KC et al. Seroprevalence of hepatitis C antibody in Peru. J Med Virol 1992; 37: 127-131.
153. Bahakim H et al. Hepatitis C virus antibodies in high-risk Saudi groups. Vox Sang 1991; 60: 162-164.
154. al-Faleh FZ et al. Prevalence of antibody to hepatitis C virus among Saudi Arabian children: A community-based study. Hepatology 1991; 14: 215-218.
155. al Nasser MN et al. Seropositivity to hepatitis C virus in Saudi haemodialysis patients. Vox Sang 1992; 62: 94-97.
156. al Karawi MA et al. Hepatitis C virus infection in chronic liver disease and hepatocellular carcinoma in Saudi Arabia. J Gastroenterol Hepatol 1992; 7: 237-239.
157. al-Faleh FZ et al. Profile of hepatitis C virus and the possible modes of transmission of the virus in the Gizan area of Saudi Arabia: A community-based study. Ann Trop Med Parasitol 1995; 89: 431-437.
158. Chen DS et al. Hepatitis C virus infection in Taiwan. Gastroenterol Japon 1991; 26 (Suppl. 3): 164-166.
159. Lee SD et al. Seroepidemiology of hepatitis C virus infection in Taiwan. Hepatology 1991; 13: 830-833.
160. Chien RN et al. Low prevalences of HBV and HCV infection in patients with primary biliary cirrhosis in Taiwan: A case control study. J Gastroenterol Hepatol 1993; 8: 574-576.
161. Chang MH et al. Minimal role of hepatitis C virus infection in childhood liver diseases in an area hyperendemic for hepatitis B infection. J Med Virol 1993; 40: 322-325.
162. Chuang WL et al. The role of hepatitis C virus in chronic hepatitis B virus infection. Gastroenterol Japon 1993; 28 (Suppl. 5): 23-27.
163. Chang SJ et al. Risk factors of hepatitis C virus infection in a Taiwanese aboriginal community. Kao-Hsiung I Hsueh Ko Hsueh Tsa Chih [Kaohsiung J Med Sci] 1996; 12: 241-247.
164. Triki H et al. Seroepidemiology of hepatitis B, C and delta viruses in Tunisia. Trans R Soc Trop Med Hyg 1997; 91: 11-14.
165. Doganci L et al. Prevalence of hepatitis A, B and C in Turkey. Eur J Clin Microbiol Infect Dis 1992; 11: 661-662.
166. Hyams KC et al. Seroprevalence of hepatitis A, B, and C in a United States military recruit population. Military Med 1992; 157: 579-582.
167. Jonas MM et al. Low prevalence of antibody to hepatitis C virus in an urban adolescent population. J Pediatr 1997; 131: 314-316.
168. Alter MJ et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-562.
169. Blitz-Dorfman L et al. Serological survey of markers of infection with viral hepatitis among the Yukpa Amerindians from western Venezuela. Ann Trop Med Parasitol 1996; 90: 655-657.
170. Scott DA et al. The epidemiology of hepatitis C virus antibody in Yemen. Am J Trop Med Hyg 1992; 46: 63-68.
171. Oshitani H et al. Low prevalence of hepatitis C virus infection in Lusaka. Zambia Trans R Soc Trop Med Hygiene 1995; 89: 380.
172. Allain JP et al. Prediction of hepatitis C virus infectivity in seropositive Australian blood donors by supplemental immunoassays and detection of viral RNA. Blood 1991; 78: 2462-2468.
173. Archer GT et al. Prevalence of hepatitis C virus antibodies in Sydney blood donors. Med J Aust 1992; 157: 225-227.
174. Mison LM et al. Prevalence of hepatitis C virus and genotype distribution in an Australian volunteer blood donor population. Transfusion 1997; 37: 73-78.
175. Khan M et al. Comparison of seroepidemiology of hepatitis C in blood donors between Bangladesh and Japan. Gastroenterol Japon 1993; 28 (suppl 5): 28-31.
176. Vasconcelos HC et al. Hepatitis B and C prevalences among blood donors in the south region of Brazil. Memorias Do Instituto Oswaldo Cruz 1994; 89: 503-507.
177. Ito S et al. Epidemiological characteristics of the incidence of hepatitis C virus (C100-3) antibodies in patients with liver diseases in the inshore area of the Yangtze River. J Gastroenterol Hepatol 1993; 8: 232-237.
178. Wang Y et al. Hepatitis C virus RNA and antibodies among blood donors in Beijing. J Hepatol 1994; 21: 634-640.
179. Arthur RR et al. Hepatitis C antibody prevalence in blood donors in different governorates in Egypt. Trans R Soc Trop Med Hyg 1997; 91: 271-274.
180. Schottstedt V et al. PCR for HBV, HCV and HIV-1 experiences and first results from a routine screening programme in a large blood transfusion service. Biologicals 1998; 26: 101-104.
181. Song P et al. Markers of hepatitis C and B virus infections among blood donors in Ho Chi Minh City and Hanoi. Vietnam Clin Diagnostic Lab Immunol 1994; 1: 413-418.
182. Lin CK et al. A study of hepatitis C virus antibodies and serum alanine amino transferase in blood donors in Hong Kong Chinese. Vox Sang 1992; 62: 98-101.
183. Panigrahi AK et al. Magnitude of hepatitis C virus infection in India: Prevalence in healthy blood donors, acute and chronic liver diseases. J Med Virol 1997; 51: 167-174.
184. Budihusodo U et al. Seroepidemiology of HBV and HCV infection in Jakarta, Indonesia. Gastroenterol Japon 1991; 26 (Suppl. 3): 196-201.
185. Amirudin R et al. Hepatitis B and C virus infection in Ujung Pandang, Indonesia. Gastroenterol Japon 1991; 26 (Suppl. 3): 184-188.
186. Sulaiman HA et al. Prevalence of hepatitis B and C viruses in healthy Indonesian blood donors. Trans R Soc Trop Med Hyg 1995; 89: 167-170.
187. Darmadi S et al. Hepatitis C virus infection-associated markers in sera from blood donors in Surabaya. Indonesia Microbiol Immunol 1996; 40: 401-405.
188. Prati D et al. The incidence and risk factors of community-acquired hepatitis C in a cohort of Italian blood donors. Hepatology 1997; 25: 702-704.
189. Tanaka E et al. Prevalence of antibody to hepatitis C virus in Japanese schoolchildren: Comparison with adult blood donors. Am J Trop Med Hyg 1992; 46: 460-464.
190. Watanabe J et al. Predictive value of screening tests for persistent hepatitis C virus infection evidenced by viraemia. Japanese experience. Vox Sang 1993; 65: 199-203.
191. Sasaki F et al. Very low incidence rates of community-acquired hepatitis C virus infection in company employees, long-term inpatients, and blood donors in Japan. J Epidemiol 1996; 6: 198-203.
192. Tanaka H et al. The risk of hepatitis C virus infection among blood donors in Osaka. Japan J Epidemiol 1998; 8: 292-296.
193. Kim BS et al. Prevalence of hepatitis C virus related to liver diseases in Korea. Gastroenterol Japon 1993; 28 (Suppl. 5): 17-22.
194. Araj GF et al. Hepatitis C virus: Prevalence in Lebanese blood donors and brief overview of the disease. J Med Libanais - Lebanese Med Journal 1995; 43: 11-16.
195. Morris K et al. Completed hepatitis C lookback in Northern Ireland. Transfusion Med 1997; 7: 269-275.
196. Kakepoto GN et al. Epidemiology of blood-borne viruses: A study of healthy blood donors in Southern Pakistan. Southeast Asian J Trop Med Public Health 1996; 27: 703-706.
197. Arguillas MO et al. Seroepidemiology of hepatitis C virus infection in the Philippines: A preliminary study and comparison with hepatitis B virus infection among blood donors, medical personnel, and patient groups in Davao. Philippines Gastroenterol Japon 1991; 26 (Suppl. 3): 170-175.
198. Abdourakhmanov DT et al. Epidemiological and clinical aspects of hepatitis C virus infection in the Russian Republic of Daghestan. Eur J Epidemiol 1998; 14: 549-553.
199. Abdelaal M et al. Epidemiology of hepatitis C virus: A study of male blood donors in Saudi Arabia. Transfusion 1994; 34: 135-137.
200. Crawford RJ et al. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors. Transfusion Med 1994; 4: 121-124.
201. Wang JE. A study on the epidemiology of hepatitis C infection among blood donors in Singapore. J Public Health Med 1995; 17: 387-391.
202. Tucker TJ et al. Hepatitis C virus infection rate in volunteer blood donors from the Western Cape - Comparison of screening tests and PCR. South African Med J 1997; 87: 603-605.
203. Lissen E et al. Hepatitis C virus infection among sexually promiscuous groups and the heterosexual partners of hepatitis C virus infected index cases. Eur J Clin Microbiol Infect Dis 1993; 12: 827-831.
204. Munoz-Gomez R et al. Hepatitis C virus infection in Spanish volunteer blood donors: HCV RNA analysis and liver disease. Eur J Gastroenterol Hepatol 1996; 8: 273-277.
205. Chen DS et al. Hepatitis C virus infection in an area hyperendemic for hepatitis B and chronic liver disease: The Taiwan experience. J Infect Dis 1990; 162: 817-822.
206. Songsivilai S et al. High prevalence of hepatitis C infection among blood donors in northeastern Thailand. Am J Trop Med Hyg 1997; 57: 66-69.
207. Mutimer DJ et al. Hepatitis C virus infection in the asymptomatic British blood donor. J Viral Hepat 1995; 2: 47-53.
208. Stevens CE et al. Epidemiology of hepatitis C virus. A preliminary study in volunteer blood donors. JAMA 1990; 263: 49-53.
209. Anderson SC et al. Comparison of two second-generation anti-hepatitis C virus ELISA on 21431 US blood donor samples. J Viral Hepat 1995; 2: 55-61.
210. Murphy EL et al. Demographic determinants of hepatitis C virus seroprevalence among blood donors. JAMA 1996; 275: 995-1000.
211. Chuang TY et al. Porphyria cutanea tarda and hepatitis C virus: A case-control study and meta-analysis of the literature. J Am Acad Dermatol 1999; 41: 31-36.
212. el Guneid AM et al. Prevalence of hepatitis B, C, and D virus markers in Yemeni patients with chronic liver disease. J Med Virol 1993; 40: 330-333.
213. Frider B et al. Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterol Latinoamericana 1994; 24: 71-75.
214. Jadoul M et al. Prevalence of hepatitis C antibodies in health-care workers [letter; comment]. Lancet 1994; 344: 339.
215. Vanderborght BO et al. High prevalence of hepatitis C infection among Brazilian hemodialysis patients in Rio de Janeiro: A one-year follow-up study. Revista Do Instituto Med Trop Sao Paulo 1995; 37: 75-79.
216. Germanaud J et al. The occupational risk of hepatitis C infection among hospital employees. Am J Public Health 1994; 84: 122.
217. Schlipkoter U et al. Transmission of hepatitis C virus (HCV) from a haemodialysis patient to a medical staff member. Scand J Infect Dis 1990; 22: 757-758.
218. Jochen AB. Occupationally acquired hepatitis C virus infection [letter; comment]. Lancet 1992; 339: 304
219. Ribero ML et al. Prevalence of HCV antibody among Italian dental practitioners. Third Int Symp HCV, Strasbourg, 96 (Abstract), 1991.
220. Campello C et al. Prevalence of HCV antibodies in healthcare workers from northern Italy. Infection 1992; 20: 224-226.
221. Petrosillo N et al. Hepatitis B virus, hepatitis C virus and human immunodeficiency virus infection in health care workers: A multiple
222. Nakashima K et al. Low prevalence of hepatitis C virus infection among hospital staff and acupuncturists in Kyushu. Japan J Infect 1993; 26: 17-25.
223. Fujiyama S et al. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff. Hepato-Gastroenterology 1995; 42: 162-165.
224. Rehman K et al. Prevalence of seromarkers of HBV and HCV in health care personnel and apparently healthy blood donors. JPMA - J Pakistan Med Assoc 1996; 46: 152-154.
225. Mujeeb SA et al. Frequency of parenteral exposure and seroprevalence of HBV, HCV, and HIV among operation room personnel. J Hosp Infect 1998; 38: 133-137.
226. Soni PN et al. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. J Med Virol 1993; 40: 65-68.
227. Struve J et al. Prevalence of antibodies against hepatitis C virus infection among health care workers in Stockholm. Scand J Gastroenterol 1994; 29: 360-362.
228. Liaw YF et al. Hepatitis C virus infection in patients with chronic liver diseases in an endemic area for hepatitis B virus infection. Gastroenterol Japon 1991; 26 (suppl 3): 167-169.
229. Oge O et al. Occupational risk of hepatitis B and C infections in urologists. Urol Intis 1998; 61: 206-209.
230. Mortimer PP et al. Hepatitis C virus antibody. Lancet 1989; 2: 798.
231. Herbert AM et al. Occupationally acquired hepatitis C virus infection. Lancet 1992; 339: 305.
232. Neal KR et al. Prevalence of hepatitis C antibodies among healthcare workers of two teaching hospitals. Who is at risk? BMJ 1997; 314: 179-180.
233. Lodi G et al. Prevalence of HCV infection in health care workers of a UK dental hospital. Br Dental J 1997; 183: 329-332.
234. Abb J. Prevalence of hepatitis C virus antibodies in hospital personnel. Zentralblatt Fur Bakteriologie 1991; 274: 543-547.
235. Shapiro CN et al. Use of the hepatitis-B vaccine and infection with hepatitis B and C among orthopaedic surgeons. The American Academy of Orthopaedic Surgeons Serosurvey Study Committee. J Bone Joint Surg Am 1996; 78: 1791-1800.
236. Cooper BW et al. Seroprevalence of antibodies to hepatitis C virus in high-risk hospital personnel. Infect Control Hosp Epidemiol 1992; 13: 82-85.
237. Thomas DL et al. Viral hepatitis in health care personnel at The Johns Hopkins Hospital. The seroprevalence of and risk factors for hepatitis B virus and hepatitis C virus infection. Arch Intern Med 1993; 153: 1705-1712.
238. Polish LB et al. Risk factors for hepatitis C virus infection among health care personnel in a community hospital. Am J Infect Control 1993; 21: 196-200.
239. Niu MT et al. Multicenter study of hepatitis C virus infection in chronic hemodialysis patients and hemodialysis center staff members. Am J Kidney Dis 1993; 22: 568-573.
240. Forseter G et al. Hepatitis C in the health care setting. II. Seroprevalence among hemodialysis staff and patients in suburban New York City. Am J Infect Control 1993; 21: 5-8.
241. Gerberding JL. Incidence and prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and cytomegalovirus among health care personnel at risk for blood exposure: Final report from a longitudinal study. J Infect Dis 1994; 170: 1410-1417.
242. Goetz AM et al. Prevalence of hepatitis C infection in health care workers affiliated with a liver transplant center. Transplantation 1995; 59: 990-994.
243. Panlilio AL et al. Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am College Surgeons 1995; 180: 16-24.
244. Tokars JI et al. National surveillance of dialysis associated diseases in the United States. 1995 ASAIO J 1998; 44: 98-107.
245. Davis AR et al. Hepatitis C virus transmission to heterosexual partner: Bedroom or bathroom hazard? Med J Aust 1996; 164: 126.
246. Kolho E et al. Transmission of hepatitis C virus to sexual partners of seropositive patients with bleeding disorders: A rare event. Scand J Infect Dis 1991; 23: 667-670.
247. Meisel H et al. Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet 1995; 345: 1209-1211.
248. Brettler DB et al. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C-infected hemophilic males: An international, multicenter study. Blood 1992; 80: 540-543.
249. Power JP et al. Hepatitis C infection from anti-D immunoglobulin [letter; comment]. Lancet 1995; 346: 372-373.
250. Scotto G et al. Sexual transmission of hepatitis C virus infection. Eur J Epidemiol 1996; 12: 241-244.
251. Akahane Y et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120: 748-752.
252. Koda T et al. Hepatitis C transmission between spouses. J Gastroenterol Hepatol 1996; 11: 1001-1005.
253. Mauser-Bunschoten EP et al. Transmission of hepatitis C virus to spouses [letter; comment]. Ann Intern Med 1995; 122: 154-155.
254. Win N et al. The low risk of hepatitis C virus transmission among sexual partners of confirmed HCV-positive blood donors. Transfusion Med 1994; 4: 243-244.
255. Diago M et al. Intrafamily transmission of hepatitis C virus: Sexual and non-sexual contacts. J Hepatol 1996; 25: 125-128.
256. Saltoglu N et al. Sexual and non-sexual intrafamilial spread of hepatitis C virus: Intrafamilial transmission of HCV. Eur J Epidemiol 1998; 14: 225-228.
257. Gordon SC et al. Lack of evidence for the heterosexual transmission of hepatitis C. Am J Gastroenterol 1992; 87: 1849-1851.
258. Quaranta JF et al. Prevalence of antibody to hepatitis C virus (HCV) in HIV-1-infected patients (nice SEROCO cohort). J Med Virol 1994; 42: 29-32.
259. van Doornum GJ et al. Prevalence of hepatitis C virus infections among heterosexuals with multiple partners. J Med Virol 1991; 35: 22-27.
260. Corona R et al. Heterosexual and homosexual transmission of hepatitis C virus: Relation with hepatitis B virus and human immunodeficiency virus type 1. Epidemiol Infect 1991; 107: 667-672.
261. Weinstock HS et al. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 1993; 269: 392-394.
262. Thomas DL et al. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis 1994; 169: 990-995.
263. Gust I et al. Prevalence of infection with hepatitis C virus in Australia. Med J Aust 1989; 151: 719-18.
264. Melbye M et al. Sexual transmission of hepatitis C virus: Cohort study 1981-9 among European homosexual men. BMJ 1990; 301: 210-212.
265. Westh H et al. Hepatitis C virus antibodies in homosexual men and intravenous drug users in Denmark. Infection 1993; 21: 115-117.
266. Hadziyannis SJ et al. Hepatitis C virus infection in Greece and its role in chronic liver disease and hepatocellular carcinoma. J Hepatol 1993; 17 (suppl 3): S72-7.
267. Gasparini V et al. Hepatitis C virus infection in homosexual men: A seroepidemiological study in gay clubs in northeast Italy. Eur J Epidemiol 1991; 7: 665-669.
268. Ricchi E et al. Anti-hepatitis C virus antibodies amongst Italian homo-bisexual males. Eur J Epidemiol 1992; 8: 804-807.
269. Donahue JG et al. Antibody to hepatitis C virus among cardiac surgery patients, homosexual men, and intravenous drug users in Baltimore. Maryland Am J Epidemiol 1991; 134: 1206-1211.
270. Tor J et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ 1990; 301: 1130-1133.
271. Sanchez-Quijano A et al. Hepatitis C virus infection in sexually promiscuous groups. Eur J Clin Microbiol Infect Dis 1990; 9: 610-612.
272. Sonnerborg A et al. Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection. Infection 1990; 18: 347-351.
273. Osmond DH et al. Comparison of risk factors for hepatitis C and hepatitis B virus infection in homosexual men. J Infect Dis 1993; 167: 66-71.
274. Buchbinder SP et al. Hepatitis C virus infection in sexually active homosexual men. J Infect 1994; 29: 263-269.
275. Ndimbie OK et al. Hepatitis C virus infection in a male homosexual cohort: Risk factor analysis. Genitourin Med 1996; 72: 213-216.
276. Osella AR et al. Hepatitis B and C virus sexual transmission among homosexual men. Am J Gastroenterol 1998; 93: 49-52.
277. Wu JC et al. Prevalence, infectivity, and risk factor analysis of hepatitis C virus infection in prostitutes. J Med Virol 1993; 39: 312-317.
278. Develoux M et al. Hepatitis C virus antibodies in prostitutes in Niger. Trans R Soc Trop Med Hyg 1994; 88: 536.
279. Gutierrez P et al. Prevalence of anti-hepatitis C virus antibodies in positive FTA-ABS non-drug abusing female prostitutes in Spain. Sex Transm Dis 1992; 19: 39-40.
280. Crofts N et al. Hepatitis C virus infection among a cohort of Victorian injecting drug users. Med J Aust 1993; 159: 237-241.
281. Crofts N et al. Methadone maintenance and hepatitis C virus infection among injecting drug users. Addiction 1997; 92: 999-1005.
282. van Beek I et al. Infection with HIV and hepatitis C virus among injecting drug users in a prevention setting: Retrospective cohort study. BMJ 1998; 317: 433-437.
283. Chang CJ et al. Hepatitis C virus infection among short-term intravenous drug users in southern Taiwan. Eur J Epidemiol 1999; 15: 597-601.
284. Smyth BP et al. Bloodborne viral infection in Irish injecting drug users. Addiction 1998; 93: 1649-1656.
285. Stark K et al. Frontloading: A risk factor for HIV and hepatitis C virus infection among injecting drug users in Berlin. AIDS 1996; 10: 311-317.
286. Van den Hoek JA et al. Prevalence, incidence, and risk factors of hepatitis C virus infection among drug users in Amsterdam. J Infect Dis 1990; 162: 823-826.
287. Van Ameijden EJ et al. A longitudinal study on the incidence and transmission patterns of HIV, HBV and HCV infection among drug users in Amsterdam. Eur J Epidemiol 1993; 9: 255-262.
288. Galeazzi B et al. Hepatitis C virus infection in Italian intravenous drug users: Epidemiological and clinical aspects. Liver 1995; 15: 209-212.
289. Woodfield DG et al. Hepatitis C virus infections in oral and injectable drug users. NZ Med J 1993; 106: 332-334.
290. Robinson GM et al. Hepatitis C prevalence and needle/syringe sharing behaviours in recent onset injecting drug users. NZ Med J 1995; 108: 103-105.
291. Kemp et al. Injecting behaviours and prevalence of hepatitis B, C and D markers in New Zealand injecting drug user populations. NZ Med J 1998; 111: 50-53.
292. Hagan H et al. Syringe exchange and risk of infection with hepatitis B and C viruses. Am J Epidemiol 1999; 149: 203-213.
293. Bolumar F et al. Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain. 1990-92. Int J Epidemiol 1996; 25: 204-209.
294. Santana Rodriguez OE et al. Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 1998; 14: 555-561.
295. Garfein RS et al. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users. JAIDS 1998; 18 (suppl 1): S11-9.